Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus

ClinicalTrials.gov ID: NCT02041091

Public ClinicalTrials.gov record NCT02041091. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 3, 2026, 1:13 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Systemic Lupus Erythematosus

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the amount of tabalumab in the blood after it is given by two different injection methods - A traditional syringe or a spring loaded syringe for 12 weeks. Participants may continue to receive study drug for up to 52 weeks.

Study identification

NCT ID
NCT02041091
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
226 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 2013
Primary completion
Sep 30, 2014
Completion
Oct 31, 2015
Last update posted
Jun 14, 2018

2014 – 2015

United States locations

U.S. sites
36
U.S. states
22
U.S. cities
35
Facility City State ZIP Site status
Medvin Clinical Research Covina California 91723
TriWest Research Associates El Cajon California 92020
ProHealth Partners Medical Group Long Beach California 90808
Wallace Rheumatic Study Center Los Angeles California 90048
Desert Medical Advances Palm Desert California 92260
Inlande Rheumatology Clinical Trials Upland California 91786
Denver Arthritis Center Denver Colorado 80230
New England Research Associates Trumbull Connecticut 06611
Advanced Pharma Clinical Research Miami Florida 33136
New Horizon Research Center Miami Florida 33175
Arthritis Research of Florida Palm Harbor Florida 34684
Clinical Research of West Florida, Inc. Tampa Florida 33603
Indiana University Health Indianapolis Indiana 46202
The Arthritis & Diabetes Clinic Inc. Monroe Louisiana 71203
West Michigan Rheumatology Grand Rapids Michigan 49546
Clayton Medical Research St Louis Missouri 63117
Physician Research Collaboration, LLC Lincoln Nebraska 68516
Westroads Clinical Research-Omaha Omaha Nebraska 68114
Innovative Health Research Las Vegas Nevada 89128
(AOA) Arthritis & Osteoporosis Associates Freehold New Jersey 07728
Albuquerque Clinical Trials Albuquerque New Mexico 87102
The Feinstein Institute for Medical Research Manhasset New York 11030
Box Arthritis & Rheumatology of the Carolinas, PLLC Charlotte North Carolina 28210
PharmQuest Greensboro North Carolina 27408
Shanahan Rheumatology & Immunotherapy Raleigh North Carolina 27617
PMG Research of Salisbury Salisbury North Carolina 28144
Paramount Medical Research Middleburg Heights Ohio 44130
Oklahoma Arthritis Center Edmond Oklahoma 73013
Altoona Center for Clinical Research Duncansville Pennsylvania 16635
Clinical Research Center of Reading, LLP Wyomissing Pennsylvania 19610
Low Country Research Center North Charleston South Carolina 29406
Tekton Research, Inc. Austin Texas 78745
Sun Research Institute San Antonio Texas 78215
Virginia Clinical Research Norfolk Virginia 23507
Arthritis Northwest Rheumatology Spokane Washington 99204
Mountain State Clinical Research Clarksburg West Virginia 26301

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 8 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02041091, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 14, 2018 · Synced Sep 3, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02041091 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →